{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:45:26Z","timestamp":1777524326039,"version":"3.51.4"},"reference-count":8,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[1980,7,1]],"date-time":"1980-07-01T00:00:00Z","timestamp":331257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr (Phila)"],"published-print":{"date-parts":[[1980,7]]},"abstract":"<jats:p>Two pediatricians failed to recognize Gilles de la Tourette syndrome in a child. The symptoms were exacerbated after the child took both pemoline and methylphenidate. All medications commonly used to treat hyperactivity may cause such exacerbation. Gilles de la Tourette syndrome is frequently asso ciated with symptoms characteristic of hyperactivity and often goes unrecog nized for long periods of time. The symptoms of the syndrome and the evidence that they are exacerbated by medication used to hyperactivity are briefly reviewed. Physicians should be aware of the possibility of Gilles de la Tourette syndrome in any hyperactive patient who manifests or has a history of a tic.<\/jats:p>","DOI":"10.1177\/000992288001900704","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T18:00:38Z","timestamp":1217268038000},"page":"453-454","source":"Crossref","is-referenced-by-count":21,"title":["Deleterious Effects of Drugs Used for Hyperactivity on Patients with Gilles de la Tourette Syndrome"],"prefix":"10.1177","volume":"19","author":[{"given":"Esther K.","family":"Sleator","sequence":"first","affiliation":[{"name":"Institute of Child Behavior and Development, University of Illinois, 51 Gerty Drive, Champaign, Illinois 61820"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1980,7,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1974.tb02715.x"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1977.02120180045008"},{"key":"atypb3","volume":"14","author":"Shapiro AK","year":"1976","journal-title":"Adv Neurol"},{"key":"atypb4","unstructured":"Meyerhoff JL , Snyder SH: Catecholamines in Gilles de la Tourette's disease: a clinical study with amphetamine isomers. Adv Neurol 14, New York, Raven Press, 1973, pp 123-134"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770260123015"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.134.2.195"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1177\/000992287401300103"},{"key":"atypb8","volume-title":"Personal communication","author":"Sleator EK"}],"container-title":["Clinical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/000992288001900704","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/000992288001900704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:23:13Z","timestamp":1777393393000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/000992288001900704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1980,7]]}},"alternative-id":["10.1177\/000992288001900704"],"URL":"https:\/\/doi.org\/10.1177\/000992288001900704","relation":{},"ISSN":["0009-9228","1938-2707"],"issn-type":[{"value":"0009-9228","type":"print"},{"value":"1938-2707","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,7]]}}}